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Abstract 
Background/Significance: Dementia is a leading cause of dependence and a common 
comorbidity in older women who are also diagnosed with breast cancer. Many older women with 
dementia die within six months of a cancer diagnosis. This project is significant in that many 
older breast cancer patients are also diagnosed with dementia, which can impact the diagnosis 
and treatment of the malignancy. Purpose:  The purpose of this research is to describe the 
incidence, demographic characteristics and types of cognitive deficits in older breast cancer 
patients as detected by administering the clock-drawing test (CDT). The Theoretical 
framework used for the research is the Health Promotion Model, because many older patients 
realize they are having cognitive changes and compensate in order to maintain independence as 
long as possible. Methods: This prospective, descriptive study included women aged 69 years 
and over with a diagnosis of breast cancer. Any stage of breast cancer and type of treatment were 
included. The Clock Drawing test (CDT) Results: The mean age (n=42) was 78 years. 25 
(59.5%) were diagnosed with infiltrating ductal carcinoma with 11% being metastatic. 71.4% 
(30) patients scored abnormal on the clock drawing test. 22 (52.4%) had spatial/planning deficits 
and 10 (23.8%) exhibited size difficulties. Six (6) people (14.3%) showed conceptual deficits and 
five (5) people were found to have perseveration deficits (11.9%). Nine (21.4%) participants 
were found to have two or more abnormalities in the categories. Conclusion: Dementia 
screening should be part of the comprehensive physical assessment of the older person diagnosed 
with cancer due to the amount of patients who screen positive for dementia using the CDT.     
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Chapter 1 
The World Health Organization (WHO) states that approximately 47.5 million people 
worldwide are affected with dementia, and 7.7 million new cases are recognized annually (World 
Health Organization, 2015).  The prevalence of dementia has increased over recent years, which 
may be associated with the increase in the numbers of people aged 65 years and over in the 
United States (Rocca et al., 2011).  
According to the SEER data, three out of 100 women over the age of 60 years will 
develop breast cancer over the course of ten years (National Cancer Institute, 2014).  Breast 
cancer is commonly diagnosed in women aged 55-64 years and the median age of diagnosis is 61 
years (National Cancer Institute, 2014).  In patients aged 68 years and over, 7.4% of breast 
cancer patients had a preexisting diagnosis of dementia, especially prevalent in people who were 
black, unmarried, impoverished, less educated and with multiple comorbities (Raji, Kuo, 
Freeman, & Goodwin, 2008).  Some older women develop dementia after diagnosis and 
treatment of breast cancer (Mandelblatt et al., 2014).  It is important to recognize and diagnose 
dementia in older breast cancer patients because there is an increased risk for mortality when a 
woman has both breast cancer and dementia.  Approximately, 33.3% of older breast cancer 
patients with dementia will die within six months of a cancer diagnosis as compared to 8.5% 
without a diagnosis of dementia (Raji et al., 2008).  Many older women diagnosed with breast 
cancer currently, will experience a diagnosis of dementia. 
Purpose and Significance 
The purpose of this research is to describe the incidence, demographic characteristics and 
types of cognitive deficits in older breast cancer patients as detected by administering the clock-
drawing test (CDT). This project is significant in that millions of cases of dementia and breast 
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cancer are diagnosed annually around the world and in the United States (World Health 
Organization, 2015). It is important to illuminate the coexistence of dementia in older breast 
cancer patients so that early detection can help with planning and management of cognitive 
decline, and with decisions regarding cancer treatment.    
Specific Aims 
1. Describe the demographic characteristics of the older women diagnosed with breast 
cancer who underwent cognitive screening. 
2. Describe the incidence of positive cognitive screening using the clock-drawing test in 
older breast cancer patients. 
3. Characterize cognitive abnormalities by organizing groups of similar clock drawings.   
Theoretical Framework 
The Health Promotion Model (Pender, Murdaugh, & Parsons, 2011) defines health as an 
ever-changing state as compared to the absence of disease and is the patient's level of well-being. 
The Health Promotion Model (HPM) is the framework for this research in that many people may 
realize that they are having cognitive limitations. Often patients can compensate and maintain 
independence until dementia advances to a level that memory is overtly impaired.  Cognition is 
one element of health and many can maintain a sense of “healthy” despite a diagnosis of breast 
cancer and early dementia.  Health is dynamic, especially with aging, and the HPM contents that 
with managed comorbid conditions, people can lead an independent life (Pender et al., 2011).   
Definition of Dementia 
The Centers for Disease Control (CDC) defines dementia as a term for a group of 
cognitive disorders that consist of memory impairment, behavioral disabilities and disturbances 
of executive function (Centers for Disease Control, 2015).   Dementia serves as a general term 
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relating to the chronic irreversible damage caused to the cognitive functioning and memory 
impairment (Jablonski, 2013).   Dementia is a non-reversible disease effecting cognitive ability 
and is considered a leading health problem in the United States (Iadecola, 2013).   
To diagnose dementia, a decline in mentation must be appreciated (The American 
Psychological Assocaition, 2016).   In addition to mental status changes, behavioral changes may 
also occur such as agitation, aggression and anxiety.  Currently, there are no known clinical 
markers to identify a diagnosis of dementia (Noe et al., 2004), however there are predictive 
features. Lower levels of education (Sharp & Gatz, 2011), advancing age (Iadecola, 2013), the 
presence of rosacea (Egeberg, Hansen, Gislason, & Thyssen, 2016), robust alcohol consumption, 
heavy smoking and diabetes are risk factors for dementia (Yang et al., 2016).   
The American Psychiatric Association, the National Institute of Neurological and 
Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders 
Association suggestion that diagnostic criteria for dementia should include a comprehensive 
history and physical examination, and specialized tests to determine memory and cognitive 
function limitation.  Diagnoses include extent of cognitive impairment and memory disorder, and 
may accompany diagnoses of depression and anxiety disorders (The American Psychological 
Assocaition, 2016)   
Primary care providers (PCPs) often initially address dementia in terms of screening, 
diagnosis and referral to neurology for treatment and management considerations (Galvin, 
Sadowsky, & Nincds, 2012). An algorithm has been established to aid in the diagnosis of 
dementia which includes assessing the early warning signs, using the appropriate screening tools, 
assessing the patients behavior changes, psychosis habits, and depression (Galvin et al., 2012). 
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Often, PCPs diagnose and treat dementia due to lack of resources in many communities for 
specialized memory disorder care (Darrow, 2015).   
It is important to recognize early dementia in order to facilitate a diagnosis, establish 
treatment and foster behavioral modifications that can support the patient and family (Sadowsky 
& Galvin, 2012). Early detection allows for planning to help support independence for as long as 
possible and arrange quality geriatric psychological care (Bradford, Kunik, Schulz, Williams, & 
Singh, 2009). Treatment with anti-dementia drugs, such as cholinesterase inhibitors, are often 
used in early diagnosed dementia patients as compared to late disease (Koller, Hua, & Bynum, 
2016). However, no treatment intervention has prevented the progression of dementia from a 
mild cognitive disorder to a diagnosis of dementia (Kelley, 2015).    
There are many forms of dementia such as vascular dementias, cognitive impairment, 
Lewy body dementia and Alzheimer’s disease (Alzheimer's Assocaition, 2016a).  According to 
Medicare, Alzheimer’s disease (AD) is the most prevalent dementia (43.5%), then vascular 
dementia (14.5%), and followed by Lewy body dementia (4.5%) (Goodman et al., 2016).  
Depending on the type of dementia, various behaviors may be more evident. Word finding, facial 
recognition, and impaired reasoning and decision making are all associated with a diagnosis of 
AD (Alzheimer's Assocaition, 2016b).  Lewy body dementia may exhibit with Parkinsonian 
signs and hallucinations (Jablonski, 2013).  Vascular dementia may present with general gait 
alterations and problems with executive functioning (Davis, Hendrix, & Superville, 2011).  The 
specific type of dementia can be evident on diagnostic behaviors and screening instruments.       
Impact of Dementia on the Social Support System 
All types of dementia have a large impact on the patient’s support system.  Caregivers of 
older patients report a great deal of burden particularly in situations of psychological and 
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cognitive decline (Borman et al., 2016).  The loss of the patient’s ability to work and participate 
in meaningful activity is a difficult transition for many patients and families (Roach & 
Drummond, 2014). Being the caregiver to a person with dementia, particularly AD, is a highly 
burdensome and stressful experience and can culminate in decreased quality of life, more 
comorbidity and loss of work impacting economic condition of the family (Goren, Montgomery, 
Kahle-Wrobleski, Nakamura, & Ueda, 2016).  Caregivers to dementia patients experience 90% 
higher odds of experiencing frailty when compared to caregivers to non-dementia patients 
(Dassel & Carr, 2016).   
Long term care facility placement decisions are often motivated by moderate dementia 
and when the demand for continuous care is emergent (Porter et al., 2016).  The demand for long 
term placement for people with dementia is great and costly.  Families may have to make 
sacrifices to afford the high cost of care.   
Compound the stressors with a diagnosis of cancer that potentially requires surgery, 
radiation therapy, chemotherapy and/or hormonal therapy and support persons can be very busy 
driving to appointments, caregiving, and completing all the tasks that maintain health and 
independence of the patient.  Decisions regarding the extent of cancer treatment for a person with 
dementia pose considerable discussion among the healthcare team and the patient and family.  
The NCCN suggests palliative treatment for cancer patients with the comorbidity of dementia 
who have mental impairment such that they are unable to make personal care decisions (National 
Comprehensive Cancer Network, 2016).  The NCCN recommendations are consistent with 
current research suggesting that cancer patients who are diagnosed with dementia tend to receive 
less aggressive cancer treatment (Hopkinson, Milton, King, & Edwards, 2016).  Despite the 
recommendations and research, decisions regarding the extent of cancer treatment may not be so 
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clear and patients and families may struggle with considerations associated with quality versus 
quantity of life.   
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Chapter 2 
Review of Literature 
The following review of literature was obtained using the PubMed database and is 
focused on specific types of dementia such as Alzheimer’s disease, vascular dementia and Lewy 
body dementia. Dementia in older women with breast cancer will be discussed. The search for 
the literature began with Refworks and using search options for Online Databases. The key 
words that were searched were Alzheimer’s, Dementia, Lewy Bodies, and Vascular Dementia.  
Dementia and Breast Cancer  
The risk for developing dementia and breast cancer increases with age (National Cancer 
Institute, 2014; World Health Organization, 2015). People diagnosed with dementia are more 
likely to be diagnosed with a later stage breast cancer and have an increased risk of cancer-
related death (Raji et al., 2008). For some people, cognitive dysfunction and breast cancer are 
unrelated comorbid conditions.  In older women diagnosed with breast cancer, cognitive 
impairment may be recognized as the diagnosis of cancer and associated with various 
nonmalignant comorbidities or dementias more common with aging (diabetes, cardiovascular 
disease) (Mandelblatt et al., 2014).  
Conversely, cognitive limitations in breast cancer may be related to cancer treatment and 
not necessarily age. In women diagnosed with breast cancer and receiving chemotherapy with a 
mean age of 53 years, 46% reported self-perceived cognitive changes (Mehnert et al., 2007).  In 
large trials including human and rat models, chemotherapy is related to cognitive impairment 
(Joly et al., 2015). Cognitive abilities were found to be impaired prior to any treatment for the 
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malignancy which may be linked to Tumor Necrosis Factor (TNF) which are cytokines in 
patients affected with breast cancer (Patel et al., 2015).   
For breast cancer patients diagnosed with a coexisting dementia not related to 
chemotherapy treatment, dementia requires a great deal of care and management.  Dementia 
effects cancer screening decisions.  For women with mild to moderate dementia, patients 
continued to undergo mammography.  For women with severe dementia, screening was not 
considered as important (Smyth, 2009).  Poorer survival, less screening and cancer treatment and 
more toxicities when receiving treatment are factors expressed in a systematic review of 
dementia patients diagnosed with cancer (Hopkinson et al., 2016). The National Comprehensive 
Cancer Network (NCCN) recommends that the ability of a patient to have decision making 
capacities and to understand the diagnosis and treatment plans and appreciate their situation are 
important in deciding the type of cancer treatment strategy (National Comprehensive Cancer 
Network, 2016).  For patients who do not have the cognitive ability of decision-making, a proxy 
decision maker should be engaged in the many complex decisions of cancer treatment.  
Types of Dementia 
 It is important to illustrate the most common types of dementia that may present in 
addition to a diagnosis of breast cancer  While cognitive changes have been known to occur as a 
result of cancer treatment with chemotherapy (Joly et al., 2015), cognition discussed in this 
project was most likely a separate diagnosis.   
Alzheimer Disease   
Alzheimer disease (AD) is the most common form of dementia accounting for 
approximately 50-60% of the dementia cases (Alzheimer's Assocaition, 2016b).  AD is the sixth 
leading cause of death in the United States (Tejada-Vera, 2013).  This age-related, progressive 
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disease causes the patient memory loss in addition to changes in perception, language and 
calculation barriers (Noe et al., 2004).   Alzheimer’s is diagnosed predominantly in people aged 
85 years and over (Tejada-Vera, 2013) and symptoms include memory, language, and 
visual/spatial changes (Alzheimer's Assocaition, 2016b).  
According to the National Institute of Aging and the Alzheimer’s Association, there are 
two types of presentations upon which an AD diseases can be made; amnestic changes which are 
impairments in learning and recall of recently learned material, along with non-amnestic changes 
which consist of language changes, visuospatial and executive dysfunction (McKhann et al., 
2011). Problems with wording finding, facial recognition and impaired reasoning and decision 
making are all associated with a diagnosis of AD.  AD is associated with tissue damage in the 
hippocampus, which is the center of learning and memory in the brain (Alzheimer's Assocaition, 
2016b).   Beta-amyloid and tau are proteins that accumulate in the brain due to genetics, 
environment or lifestyle choices (Hwang et al., 2016). Treatment of AD can help slow the 
detrition of memory but is not effective in halting or preventing the disease.  Cholinesterase 
inhibitors are effective in mild to moderate AD (Birks, 2006; Birks, Grimley Evans, Iakovidou, 
Tsolaki, & Holt, 2009).   
Vascular Dementia 
 Vascular dementia, is a name for many vascular disorders that are associated with 
reduced blood flow to the brain.  Risk factors are atrial fibrillation, hypertension, diabetes 
mellitus, high cholesterol and advancing age (Gorelick et al., 2011). Vascular dementia accounts 
for 20% of the population living with dementia (Gorelick et al., 2011). When the blood flow is 
not able to efficiently perfuse the brain, tissue damage can lead to vascular dementia. Onset can 
be abrupt and can directly follow a myocardial infarction or cerebrovascular accident, or 
Running Head: DEMENTIA IN OLDER WOMEN WITH BREAST CANCER  12 
	
cognitive deterioration can have a progressive and slow effect after repeated damage to the 
vascularity of the brain (Jablonski, 2013). Signs and symptoms of vascular dementia include 
mental deterioration, gait changes and executive dysfunction (Davis et al., 2011).  Vascular 
irregularities such as cerebrovascular disease and other risk factors for vascular damage cause 
these changes in the brain.  
Biomarkers may help diagnose and monitor vascular dementia and can be an effective 
management strategy (Xiao, Zhao, Kuang, & Guan, 2016).  Reducing rates of heart disease and 
stroke can help decrease vascular dementias (Rocca et al., 2011).  Brain images are able to show 
changes in the white matter of the brain and can distinguish between Alzheimer’s dementia and 
vascular dementia. Patients are often aware of their mental status changes in this type of 
dementia (Jablonski, 2013). 
Lewy Body Dementia 
 According to the Lewy Body Dementia Association (LBDA), Lewy body dementia 
(LBD) is a diagnosis that includes Parkinson’s dementia and dementia with Lewy body’s (Lewy 
Body Dementia Association, 2016).   Dementia develops progressively but can have varying 
ranges in cognitive impairment (Noe et al., 2004). Protein deposits, called Lewy bodies, join 
together in the brainstem and brain cortical areas that are composed of the protein alpha-
synuclein. For a patient to be diagnosed with LBD, a minimum of two of signs and symptoms 
must be present: Parkinson’s motor signs, alternating attention and concentration spans along 
with hallucinations (Jablonski, 2013). Extrapyramidal symptoms include the restless leg, 
shuffling gait, facial distortions and dystonic reactions (Davis et al., 2011; Gomperts, 2016). 
Cerebrospinal biomarkers and amyloid beta markers may have some predictive ability in 
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cognitive decline in LBD (Abdelnour et al., 2016).  Also, gait difficulties can predict dementia 
(Beauchet et al., 2016).   
There are various differences in memory and mental performance between LBD and 
Alzheimer’s dementia (Gomperts, 2016). Patients with LBD perform worse on visual memory as 
compared to Alzheimer’s disease (Noe et al., 2004). LBD tends to exhibit attentional, 
visuoperceptive, and visuoconstructive deficits and Parkinson’s disease tends to show attentional 
deficits as compared to Alzheimer’s disease which displays a amnesic syndrome (Noe et al., 
2004).   The importance of nurses knowing the type of dementia allows for the individual to have 
a more focused plan of care in order to best suit their needs (Jablonski, 2013).   
Cognitive Assessment 
Screening for cognitive limitations is a critical part of the general assessment of the older 
person.  Interventions exist for people who screen positive for dementia such as physical and 
cognitive rehabilitation (Tay, Lim, Chan, Ali, & Chong, 2016), medication related treatments 
(Strohle et al., 2015) and mind-body movement exercises (Hariprasad et al., 2013). Cognitive 
limitations can be associated with chemotherapy, with the breast cancer diagnosis or as a 
comorbid condition (Hermelink, 2015).   It is important to screen for cognitive limitations in 
older women with breast cancer and should be included in base line screening prior to cancer 
treatment (National Comprehensive Cancer Network, 2016).  Two examples of cognitive 
screening are the Mini Mental State Examination (M. Folstein, S. E. Folstein, & P. R. McHugh, 
1975) and the Clock Drawing test (Rouleau, Salmon, Butters, Kennedy, & McGuire, 1992).   
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Chapter 3 
Methods 
Design 
This study was a prospective, descriptive design. 
Sample 
Women diagnosed with invasive breast cancer, aged 69 years and older were invited to 
participate. Patients were diagnosed with any stage of cancer and receiving any type of 
treatment. Participants were able to read and understand the consent form. 
Setting  
The Stefanie Spielman Comprehensive Breast Center at The Ohio State University (SSCBC) is 
an outpatient clinical and research facility.  Prevention, detection, diagnostic, treatment and 
reconstructive strategies and management are some of the services offered to people diagnosed 
with breast cancer. The clinic targeted for this research was the Senior Adult Oncology Clinic, 
which focuses on older women with breast cancer.   
Instrumentation 
    Clock Drawing Test 
Conducting the Clock Drawing Test (CDT) in the clinical setting is to screen for cognitive 
disabilities as well as dementia (Rouleau et al., 1992). Skills necessary to complete this task 
include the ability to verbally understand the directions, along with memory and spatial sense. 
The patient is presented with a pre-drawn circle and asked to draw the face of the clock along 
with a specific time (Agrell & Dehlin, 2012).  Six types of errors have been categorized on the 
CDT; Size of the clock (<1.5 inches in diameter), graphical difficulties, stimulus-bound 
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response, conceptual deficit, spatial and/or planning deficit and perseveration (Rouleau et al., 
1992).   
Graphical difficulties result from imprecise lines, distortion of the clock face, numbers 
that are difficult to interpret, or hands failing to connect in the middle of the clock.  Stimulus-
bound response is associated with the patient focusing on one aspect of the directions to draw the 
clock and is often seen in the time settings that are incorrect.  Conceptual deficits are an inability 
to recall the attributes of a clock.  Spatial and/or planning deficits are errors in the layout of the 
numbers.  Perseveration is the continuation or recurrence of activity (presence of more than two 
hands, numbers that go beyond 12).  
Patients with Parkinson’s Disease and vascular dementia often exhibit stimulus bound 
response errors on the CDT which means the drawing of the clock is guided by a single stimulus 
(when asked to draw 2:10, both hands of the clock may be set at 10 because the patient focused 
on the number 10) compared to some people with Alzheimer’s disease often make conceptually 
bound errors (Lee, Kim, Choi, & Sohn, 2009).  
Patients with Alzheimer’s disease create different errors on clock drawings as compared to other 
types of dementia. When comparing the CDT results for patients with Alzheimer’s compared to 
vascular dementia and Lewy body dementia, no significant differences were noted in 
performance on the clock drawing. However, a difference between patients with Alzheimer’s and 
Frontotemporal dementia was found, with the later scoring higher (Tan, Herrmann, Mainland, & 
Shulman, 2015). The clock-drawing test is a component of the Mini-Cog which is another screen 
for cognitive limitations (Borson, Scanlan, Brush, Vitaliano, & Dokmak, 2000). 
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Procedures 
A convenience sample of new patients who presented to the clinic and over the age of 69 years 
were invited to participate in the study. The Geriatric Nurse Practitioner (GNP) explained the 
study and obtained written consent from the patient and the designated caregiver.  Health history, 
cancer diagnoses and treatment information were obtained from the medical record for each of 
the participants..  The GNP completed the CDT on each patient when they were in the 
examination room upon initial visit. As part of the CDT, a circle was provided on hardcopy 
paper for the outline of the clock and the patient was asked to insert the numbers as represented 
on the face of a clock. Data were collected upon first encounter at the Senior Adult Oncology 
Program at the SSCBC.   
Analysis 
   To describe the demographic characteristics of the sample, descriptive statistics were 
used.  To describe the incidence of positive cognitive screening, frequencies were calculated.  To 
characterize cognitive abnormalities, the data were organized by groups of similar clock 
drawings and compared to the scoring system of the Modified Rouleau method (Rouleau et al., 
1992).   
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Chapter IV 
Results 
 To address aim 1, the study included 42 participants with a mean age of 78 years (ranging 
from 69-93).  Most of the patients were diagnosed with infiltrating ductal carcinoma 25 (59.5%), 
and 11% were metastatic.  Approximately 45.2 percent underwent lumpectomy.  Many people 
(45%) reported their health to be better as compared to people their own age (Table 1).  
 To address aim 2, 30 out of 42 (71.4%) patients scored abnormal on the clock drawing 
test according to (Rouleau et al., 1992).  To describe the abnormalities as indicated in aim 3, 10 
(23.8%) people exhibited size difficulties by not drawing the numbers at the edge of the circle 
provided for the clock drawing. Only one person exhibited graphical difficulties and one person 
experienced stimulus bound responses. Six (6) people (14.3%) showed conceptual deficits and 
22 (52.4%) had spatial/planning deficits. Five (5) people were found to have perseveration 
deficits (11.9%). Nine (21.4%) participants were found to have two or more abnormalities in the 
categories. One had both size and perseveration deficits, one had size and conceptual deficits, 
one had size and spatial deficits, four had spatial/planning limitations (along with size, 
perseveration and two had conceptual errors), one had preservation and spatial deficits and one 
person had preservation, conceptual and stimulus bound response.   
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Discussion 
The patients included in this study were breast cancer patients, who were not receiving 
chemotherapy.  Many were taking hormonal therapy as adjuvant or palliative treatment.  Some 
patients were considered frail and could not undergo surgery and were therefore maintained on 
hormonal therapy. 71.4% of the patients had some abnormality on the clock drawing test, 
however none of the patients were receiving chemotherapy and therefore did not have 
chemotherapy related dementia.  The number of people who had difficulty drawing an exact 
clock was high in our study, and higher than the Alzheimer’s Association Facts and Figures from 
2014 (Alzheimer's Assocaition, 2016a), which is 44% of people aged 75-84 years.  It is quite 
possible that many people were distracted by their oncology medical visit and were not careful 
drawing the clock during the screening evaluation, which contributed to the high number of 
abnormal tests. It is important to state that an inexact clock drawn by a patient, may not result in 
a diagnosis of dementia.   
  The patient’s drawings were categorized into six different groups. The leading error 
occurred with the placement of the clock numbers, known as a spatial/planning deficit. A 
possible explanation for this error is that the CDT was performed prior to the patients’ oncology 
appointment; all the stress of the visit may have some correlation with the patients rushing 
through the test. Patients performing the test also noted that this seemed “silly” and may not have 
taken this screening seriously. The CDT may have exposed early dementia prior to these patients 
being diagnosed, despite the fact that the CDT is not sufficient in detecting mild to early 
cognitive impairment (Ehreke et al., 2009). This data does align with a study that was done in 
2009 where patients with AD, VD and PD with dementia recorded a high number of spatial and 
planning deficits (Lee et al., 2009). For this data, qualitative measures outlined by Rouleau were 
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used alone, which have been proven to not distinguish between elders with cognitive disorders 
from those without (Parsey & Schmitter-Edgecombe, 2011; Rouleau et al., 1992). Qualitative 
categories are helpful to understand the type of dementia, a however scoring mechanism will 
help differentiate normal cognitive ability from mild impairment (Parsey & Schmitter-
Edgecombe, 2011).   
 Conceptual errors, where the clock drawn is not recognized as a clock, are associated 
with early dementia; six of the drawings fell into this category (Parsey & Schmitter-Edgecombe, 
2011).  While people with early dementia versus AD scores vary on the CDT (Babins, Slater, 
Whitehead, & Chertkow, 2008), older patients with mild cognitive changes fail to score 
differently than those without cognitive impairments (Parsey & Schmitter-Edgecombe, 
2011). Because the research done with CDT in the past typically compares patients with extreme 
cases of dementia to those without any cognitive impairments, the use of these tools to screen 
may not hold as much power as once was thought (Hubbard et al., 2008). The CDT does not 
recognize early dementia (Agrell & Dehlin, 2012) despite the relationship with the Mini-Mental 
Exam (M. F. Folstein, S. E. Folstein, & P. R. McHugh, 1975).  
 Concerning the size of the clock, ten patients drew the clock too small (26%). Which was 
consistent with a similar study, that used the CDT to relate the drawings of those diagnosed with 
mild cognitive impairment to those with Dementia to those with normal functioning, which 
resulted in a majority of size errors drawn by those with Alzheimer’s (30%) (Parsey & 
Schmitter-Edgecombe, 2011). In another study, comparing CDT of patients with Alzheimer’s 
Huntington’s disease and a control of elderly patients, the clocks that resulted smaller were of 
those patients diagnosed with Huntington’s disease (Rouleau et al., 1992).  
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Study Limitations 
The sample size was small for this initial research project.  Some projects reviewed for this 
research included as little as 60 participants up to 207.  For future research, it would be prudent 
to include more participants.  Also, it will be very important to track if patients are being 
administered aromatase inhibitors which may add to cognitive deficits (Batalo et a. 2011).   
Conclusions  
Many older patients diagnosed with breast cancer exhibit some abnormality on the CDT.  Most 
abnormalities were spatial/planning difficulties.  Dementia screening should be part of the 
comprehensive physical assessment of the older person diagnosed with cancer.    
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